Effect of Rifampicin on the Pharmacokinetics of Apatinib
Status:
Completed
Trial end date:
2017-02-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to investigate potential pharmacokinetic interaction in
healthy volunteers when apatinib is administered in combination with rifampicin. Secondary
objective is evaluating the safety and tolerability of apatinib alone and when
co-administered with rifampicin.